C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) C07D 223/14 (2006.01) C07D 403/10 (2006.01) C07D 407/12 (2006.01)
Patent
CA 2526017
The present invention provides compounds of formula (I), which, are novel antagonists for D1/D5 receptors as well as methods for preparing such compounds. In another embodiment, the invention provides pharmaceutical compositions comprising such D1/D5 receptor antagonists as well as methods of using them to treat CNS disorders, obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.
L'invention concerne des composés qui sont de nouveaux antagonistes des récepteurs D¿1?/D¿5?, ainsi que des procédés de préparation associés. Dans un autre mode de réalisation, l'invention concerne des compositions pharmaceutiques contenant lesdits antagonistes des récepteurs D¿1?/D¿5?, ainsi que des méthodes d'utilisation de ces compositions dans le traitement des troubles du système nerveux central, de l'obésité, des troubles métaboliques, des troubles alimentaires, tels que l'hyperphagie, et du diabète.
Burnett Duane A.
Greenlee William J.
Mazzola Robert
Mckittrick Brian
Qiang Li
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
5-h-benzo[d]naphth[2,1-b]azepine derivative as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1653747